Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $125.00 | 1 | 58.5% |
| Food and Beverage | $51.06 | 3 | 23.9% |
| Education | $37.69 | 2 | 17.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2022) |
| ViiV Healthcare Company | $38.23 | 2 | $0 (2021) |
| Astellas Pharma US Inc | $24.99 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $12.83 | 1 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $125.00 | 1 | Janssen Scientific Affairs, LLC ($125.00) |
| 2021 | $18.68 | 1 | ViiV Healthcare Company ($18.68) |
| 2020 | $32.38 | 2 | ViiV Healthcare Company ($19.55) |
| 2019 | $12.70 | 1 | Merck Sharp & Dohme Corporation ($12.70) |
| 2017 | $24.99 | 1 | Astellas Pharma US Inc ($24.99) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/15/2022 | Janssen Scientific Affairs, LLC | — | Grant | Cash or cash equivalent | $125.00 | General |
| 03/25/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: HIV | ||||||
| 12/10/2020 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: HIV | ||||||
| 05/15/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.83 | General |
| 11/07/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/01/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $24.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 80 | 123 | $34,699 | $8,669 |
| 2022 | 5 | 95 | 141 | $47,239 | $11,508 |
| 2021 | 4 | 84 | 129 | $44,822 | $10,589 |
| 2020 | 5 | 129 | 183 | $59,400 | $16,787 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 53 | $12,349 | $3,576 | 29.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $9,900 | $2,442 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 23 | $9,200 | $1,593 | 17.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 25 | $3,250 | $1,058 | 32.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 62 | $14,446 | $3,838 | 26.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $9,765 | $2,668 | 27.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 20 | $9,000 | $2,301 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 15 | 30 | $12,208 | $2,231 | 18.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 14 | $1,820 | $470.04 | 25.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 67 | $15,611 | $4,184 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 33 | $13,548 | $2,348 | 17.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $8,463 | $2,187 | 25.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $7,200 | $1,870 | 26.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 36 | 54 | $16,081 | $5,020 | 31.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 24 | $13,986 | $4,212 | 30.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 33 | 52 | $10,722 | $3,309 | 30.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 22 | $9,900 | $2,620 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 14 | 31 | $8,711 | $1,627 | 18.7% |
About Dr. John Baxter, MD
Dr. John Baxter, MD is a Infectious Disease healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508954835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Baxter, MD has received a total of $213.75 in payments from pharmaceutical and medical device companies, with $125.00 received in 2022. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Grant" ($125.00).
As a Medicare-enrolled provider, Baxter has provided services to 388 Medicare beneficiaries, totaling 576 services with total Medicare billing of $47,553. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Camden, NJ
- Active Since 10/11/2006
- Last Updated 06/26/2019
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1508954835
Products in Payments
- RUKOBIA (Drug) $19.55
- CABENUVA (Biological) $18.68
- ZERBAXA (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Camden
Dr. Akinwale Olatosi, M.b.b.s, M.B.B.S
Infectious Disease — Payments: $41,876
Dr. Pola Dela Torre, Md, MD
Infectious Disease — Payments: $16,627
Dana Byrne, Md, MD
Infectious Disease — Payments: $1,885
Henry Fraimow, Md, MD
Infectious Disease — Payments: $1,513
Danielle Zambrano, Do, DO
Infectious Disease — Payments: $671.74
Lisa Pedroza, Md, MD
Infectious Disease — Payments: $650.52